MetLife Investment Management’s QuidelOrtho QDEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $627K | Sell |
38,160
-664,009
| -95% | -$16.3M | ﹤0.01% | 1638 |
|
|
2025
Q4 | $20.1M | Buy |
702,169
+167,261
| +31% | +$4.53M | 0.1% | 165 |
|
|
2025
Q3 | $15.8M | Buy |
534,908
+494,421
| +1,221% | +$13.5M | 0.08% | 233 |
|
|
2025
Q2 | $1.17M | Buy |
40,487
+39,301
| +3,314% | +$1.16M | 0.01% | 1228 |
|
|
2025
Q1 | $41.5K | Buy |
1,186
+94
| +9% | +$3.83K | ﹤0.01% | 2708 |
|
|
2024
Q4 | $48.6K | Buy |
1,092
+148
| +16% | +$6.05K | ﹤0.01% | 2743 |
|
|
2024
Q3 | $43K | Sell |
944
-25,230
| -96% | -$1.02M | ﹤0.01% | 2768 |
|
|
2024
Q2 | $870K | Sell |
26,174
-1,067
| -4% | -$43.6K | 0.01% | 1420 |
|
|
2024
Q1 | $1.31M | Sell |
27,241
-716
| -3% | -$41.8K | 0.01% | 1152 |
|
|
2023
Q4 | $2.06M | Sell |
27,957
-447
| -2% | -$30.2K | 0.01% | 933 |
|
|
2023
Q3 | $2.07M | Sell |
28,404
-3,929
| -12% | -$314K | 0.02% | 887 |
|
|
2023
Q2 | $2.68M | Sell |
32,333
-373
| -1% | -$32.7K | 0.02% | 806 |
|
|
2023
Q1 | $2.91M | Sell |
32,706
-878
| -3% | -$76.4K | 0.02% | 755 |
|
|
2022
Q4 | $2.88M | Sell |
33,584
-1,146
| -3% | -$97.1K | 0.02% | 751 |
|
|
2022
Q3 | $2.48M | Buy |
34,730
+2,213
| +7% | +$198K | 0.02% | 781 |
|
|
2022
Q2 | $3.16M | Buy |
32,517
+8,014
| +33% | +$817K | 0.02% | 689 |
|
|
2022
Q1 | $2.76M | Buy |
24,503
+6,124
| +33% | +$653K | 0.02% | 853 |
|
|
2021
Q4 | $2.48M | Buy |
18,379
+178
| +1% | +$24.8K | 0.02% | 784 |
|
|
2021
Q3 | $2.57M | Sell |
18,201
-1,147
| -6% | -$154K | 0.02% | 739 |
|
|
2021
Q2 | $2.48M | Sell |
19,348
-544
| -3% | -$64K | 0.02% | 777 |
|
|
2021
Q1 | $2.54M | Sell |
19,892
-1,057
| -5% | -$195K | 0.02% | 761 |
|
|
2020
Q4 | $3.76M | Sell |
20,949
-908
| -4% | -$202K | 0.04% | 501 |
|
|
2020
Q3 | $4.79M | Sell |
21,857
-840
| -4% | -$187K | 0.05% | 330 |
|
|
2020
Q2 | $5.08M | Buy |
22,697
+7,562
| +50% | +$1.18M | 0.06% | 304 |
|
|
2020
Q1 | $1.48M | Sell |
15,135
-878
| -5% | -$71K | 0.02% | 731 |
|
|
2019
Q4 | $1.2M | Hold |
16,013
| – | – | 0.01% | 1006 |
|
|
2019
Q3 | $982K | Hold |
16,013
| – | – | 0.01% | 1074 |
|
|
2019
Q2 | $950K | Buy |
16,013
+881
| +6% | +$52.8K | 0.01% | 1128 |
|
|
2019
Q1 | $991K | Hold |
15,132
| – | – | 0.01% | 1090 |
|
|
2018
Q4 | $739K | Hold |
15,132
| – | – | 0.01% | 1151 |
|
|
2018
Q3 | $986K | Hold |
15,132
| – | – | 0.01% | 1128 |
|
|
2018
Q2 | $1.01M | Buy |
15,132
+1,229
| +9% | +$74.3K | 0.01% | 1010 |
|
|
2018
Q1 | $720K | Hold |
13,903
| – | – | 0.01% | 1160 |
|
|
2017
Q4 | $603K | Buy |
+13,903
| New | +$568K | 0.01% | 1295 |
|
Other funds holding QDEL
NM
VPM
RCMNY
VCM
MetLife Investment Management's QDEL Position: Q1 2026 in Review
MetLife Investment Management reduced its QuidelOrtho (QDEL) stake by 95% in Q1 2026, selling an estimated $16.3M and leaving 38,160 shares worth $627K. The position accounts for ﹤0.01% of the portfolio, ranked #1638.
MetLife Investment Management first reported a position in QDEL in Q4 2017 and has held it in 34 quarters since. The position peaked at $20.1M in Q4 2025. 238 funds tracked by Wall St. Rank hold QDEL as of Q1 2026.
- MetLife Investment Management held 38,160 shares of QuidelOrtho worth $627K as of Q1 2026.
- MetLife Investment Management sold 664,009 QuidelOrtho shares in Q1 2026, an estimated $16.3M.
- QuidelOrtho made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1638 holding.
- MetLife Investment Management first reported a position in QuidelOrtho in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's QuidelOrtho position peaked at $20.1M in Q4 2025.
- 238 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.